Fresenius SE & Co KGaA (FREG.DE)
27 Nov 2015
FRANKFURT, Oct 29 The head of German healthcare group Fresenius se said market turbulence in emerging market has not dimmed his view of business opportunities there.
FRANKFURT, Oct 29 Fresenius SE on Thursday lifted its full-year earnings guidance again, helped by new infusion drug launches and as its rivals in the U.S. generic infusion drug market struggle with production outages.
* Fresenius announces offering of u.s. Dollar denominated senior notes
FRANKFURT German healthcare group Fresenius SE on Wednesday lifted its full-year earnings target for the second time as its rivals in the U.S. generic infusion drug market struggled with longer-than-expected production outages.
FRANKFURT, July 29 German healthcare group Fresenius SE on Wednesday lifted its full-year earnings target for the second time as its rivals in the U.S. generic infusion drug market struggled with production outages longer than expected.
Earnings vs. Estimates
Analyst Research Reports
Provider : Wright Reports
Fresenius - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast
Provider : Finlabo SIM Spa
Fresenius SE & Co KGaA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : MarketLine
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.